The US Bankruptcy Court gave an order approving the sale of its certain assets of Allena Pharmaceuticals, Inc. on December 6, 2022. The debtor has been authorized to sell its certain assets to Heritage Global Partners, Inc for a purchase price of $0.33 million in cash. The debtor's assets include equipment assets located at the debtor's sudbury facility.